000285028 001__ 285028
000285028 005__ 20260205155156.0
000285028 0247_ $$2doi$$a10.1186/s42466-026-00464-w
000285028 0247_ $$2pmid$$apmid:41634805
000285028 0247_ $$2pmc$$apmc:PMC12870955
000285028 037__ $$aDZNE-2026-00153
000285028 041__ $$aEnglish
000285028 082__ $$a610
000285028 1001_ $$aMafael, V.$$b0
000285028 245__ $$aCollaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience.
000285028 260__ $$a[London]$$bBioMed Central$$c2026
000285028 3367_ $$2DRIVER$$aarticle
000285028 3367_ $$2DataCite$$aOutput Types/Journal article
000285028 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1770302994_11295
000285028 3367_ $$2BibTeX$$aARTICLE
000285028 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000285028 3367_ $$00$$2EndNote$$aJournal Article
000285028 520__ $$aInterdisciplinary collaboration between neurologists and cardiologists is needed to provide state-of-the art stroke care and individualized decisions about secondary prevention strategies. This highlights the need to establish working structures for joint decision-making between cardiologists and stroke neurologists. At present, studies describing the real-world decision-making as part of such brain-heart teams are scarce.We established a structured heart–brain team approach with monthly virtual neurocardiology board (NCB) meetings within a neurovascular network. We conducted a retrospective analysis of the implementation phase of NCB meetings between 2021 and 2024. We describe the structure of board meetings, patient characteristics and therapeutic and diagnostic recommendations.During the study period, 46 board meetings were held, and 255 patients were discussed. The number of referred patients increased from 32 in 2021 to 89 in 2024. The majority of patients were evaluated for patent foramen ovale (PFO) closure (n = 189, 74.1%, median age 56 years, 59.8% female) and left atrial appendage occlusion (LAAO) (n = 32, 12.5%, median age 83 years, 50% female). Further questions centered around other individual secondary prevention strategies. Among patients referred to discuss PFO closure, closure was not recommended in 43.4% of patients (n = 82), recommended depending on additional diagnostic measures in 13.8% (n = 26), considered optional in 19.6% (n = 37) and clrearly recommended in 23.3% (n = 44). Patients for whom it was not recommended were older, had more cardiovascular risk factors and were less likely to have a large PFO shunt. The main reason for the recommendation against closure was that the PFO was not considered causal for the stroke (80.5%). Among LAAO patients, participation in a randomized controlled trial was recommended in 68.8%.We successfully established and steadily expanded regular NCB meetings to provide a platform for interdisciplinary exchange and personalized stroke treatment, in particular discussion of indications for interventional procedures against cardiac embolism. Our approach may serve as a blueprint for similar collaborative approaches. Future studies are needed to assess adherence to recommendations and patient outcomes as this study lacks follow-up data.
000285028 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000285028 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000285028 650_7 $$2Other$$aBrain‒heart teams
000285028 650_7 $$2Other$$aCollaboration
000285028 650_7 $$2Other$$aLeft atrial appendage closure
000285028 650_7 $$2Other$$aPatent foramen ovale
000285028 650_7 $$2Other$$aStroke
000285028 7001_ $$aBuck, T.$$b1
000285028 7001_ $$0P:(DE-2719)9003150$$aStengl, Helena$$b2$$udzne
000285028 7001_ $$aHellwig, S.$$b3
000285028 7001_ $$aKlammer, M. G.$$b4
000285028 7001_ $$0P:(DE-2719)2811033$$aEndres, M.$$b5$$udzne
000285028 7001_ $$aReinthaler, M.$$b6
000285028 7001_ $$aBarbieri, F.$$b7
000285028 7001_ $$aAudebert, H. J.$$b8
000285028 7001_ $$aLeistner, D. M.$$b9
000285028 7001_ $$aLandmesser, U.$$b10
000285028 7001_ $$aDöhner, W.$$b11
000285028 7001_ $$aSkurk, C.$$b12
000285028 7001_ $$0P:(DE-2719)9001514$$aScheitz, J. F.$$b13
000285028 773__ $$0PERI:(DE-600)2947493-0$$a10.1186/s42466-026-00464-w$$gVol. 8, no. 1, p. 4$$n1$$p4$$tNeurological research and practice$$v8$$x2524-3489$$y2026
000285028 8564_ $$uhttps://pub.dzne.de/record/285028/files/DZNE-2026-00153.pdf$$yRestricted
000285028 8564_ $$uhttps://pub.dzne.de/record/285028/files/DZNE-2026-00153.pdf?subformat=pdfa$$xpdfa$$yRestricted
000285028 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9003150$$aExternal Institute$$b2$$kExtern
000285028 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811033$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000285028 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000285028 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-11-06
000285028 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-11-06
000285028 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2025-11-06
000285028 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2025-08-21T14:06:14Z
000285028 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2025-08-21T14:06:14Z
000285028 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2025-08-21T14:06:14Z
000285028 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2025-08-21T14:06:14Z
000285028 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-11-06
000285028 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2025-11-06
000285028 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-11-06
000285028 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-11-06
000285028 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-11-06
000285028 9201_ $$0I:(DE-2719)1811005$$kAG Endres$$lInterdisciplinary Dementia Research$$x0
000285028 980__ $$ajournal
000285028 980__ $$aEDITORS
000285028 980__ $$aVDBINPRINT
000285028 980__ $$aI:(DE-2719)1811005
000285028 980__ $$aUNRESTRICTED